The siRNA targeting PD-L1 (siPD-L1) weakened the expression of immunosuppressive PD-L1 induced by PDT, effectively triggering a robust anti-tumor immune response in a “self-synergistic” manner. This evidence concerns the gene CD274 and neoplasm.